-- Hikma Pharmaceuticals Gets $110 Million in Debt Finance From IFC
-- B y   M o h a m m a d   T a y s e e r
-- 2011-12-20T14:48:37Z
-- http://www.bloomberg.com/news/2011-12-20/hikma-pharmaceuticals-gets-110-million-in-debt-finance-from-ifc.html
Hikma Pharmaceuticals Plc (HIK) , which
sells generic and branded drugs, will receive up to $110 million
in debt finanacing from the  International Finance Corporation ,
the World Bank’s private-sector lender, to improve access to
generic medicine in the Middle East and North Africa.  “This loan will support Hikma’s ongoing program of capital
expenditure and expansion, improving healthcare in the region,”
said the IFC today in an e-mailed statement.  The IFC, which has approved $2 billion worth of investments
in the Middle East and North Africa this year, expects to invest
as much as $6 billion in the region over the next three to four
years, it said.  Hikma, based in London, was founded in Amman, Jordan in
1978 and relies on the  Middle East  and North Africa for 61
percent of revenue, the company said.  To contact the reporter on this story:
Mohammad Tayseer in Amman through the Dubai newsroom at 
   mtayseer@bloomberg.net  